LatestGlobal Warming Intensifies Risk of Natural Disasters Like Nepal Glacial Flood
Cannabis

Hemp Company Challenges DEA Over HHC Legality Under Farm Bill

Raúl del Pino
Summary

A hemp company is challenging the DEA's position on hexahydrocannabinol (HHC), reigniting the legal debate over which cannabinoids are protected under the 2018 Farm Bill. HHC is a semi-synthetic cannabinoid derived from hemp-derived Delta-8 THC, and the litigation centers on whether it falls within the Farm Bill's legal definition of hemp derivatives. This case has significant implications for the cannabis industry and consumers seeking alternative cannabinoid products. The outcome could determine the regulatory status of numerous emerging cannabinoids and shape future enforcement priorities.

Originally published on

Cannabis Magazine

By Raúl del Pino

Read full article(opens in new tab)

Fetched: August 18, 2026 at 10:02 AM

Related News

More news you might be interested in

View all
Cannabis

Federal Appeals Court Sets Timeline for Hemp and CBD Medicare Coverage Litigation

A federal appeals court has established a litigation schedule for a significant case challenging the exclusion of hemp-derived cannabidiol (CBD) products from Medicare coverage in the United States. This legal development could have substantial implications for Medicare beneficiaries seeking access to CBD and hemp-based therapeutic products for various health conditions. The case addresses whether federally legal hemp and CBD products should be covered under Medicare's pharmaceutical benefits, potentially expanding treatment options for eligible patients. The established timeline will determine when arguments will be heard and decisions rendered on this important healthcare access issue.

yesterday
Cannabis Magazine
Cannabis
AnxietyDepression

Study Links Psilocybin Decriminalization to Improved Perceived Safety and Wellness

A community survey published in Social Sciences reveals that psilocybin decriminalization is associated with improvements in perceived safety, access to mental health resources, and overall community wellbeing. The research suggests that removing criminal penalties for psychedelics may reduce stigma and increase individuals' willingness to seek therapeutic support. These findings are significant for mental health policy in Puerto Rico, where access to innovative treatments for depression, anxiety, and PTSD remains limited. The study contributes to growing evidence supporting regulated access to psilocybin-assisted therapy as a complement to traditional mental health treatments.

yesterday
Cannabis Magazine
Dave Asprey: How Biohacking Became a Gateway to Higher Consciousness
Cannabis

Dave Asprey: How Biohacking Became a Gateway to Higher Consciousness

Biohacking pioneer Dave Asprey discusses how optimization practices serve as a foundation for exploring psychedelics, plant medicine, and consciousness expansion. Asprey connects biohacking principles—diet, sleep, and cognitive enhancement—with psychedelic integration and spiritual growth. The conversation explores how intentional lifestyle modifications can prepare the mind and body for transformative experiences with plant-based compounds. For those interested in holistic wellness and consciousness exploration, understanding this integration approach offers insights into combining conventional health optimization with alternative therapeutic modalities.

yesterday
High Times
MJBizDaily
Cannabis

Nearly 900 Applicants Compete for 77 Missouri Marijuana Licenses in Rebuilt Regulatory System

Missouri's medical marijuana program enters its final microbusiness licensing round with heightened competition and stricter ownership requirements following previous mass license revocations. Nearly 900 applicants are vying for just 77 available licenses in a restructured regulatory framework designed to prevent past compliance failures. The state implemented tougher ownership rules to ensure accountability and operational integrity. This competitive licensing environment reflects growing market demand for medical cannabis access while maintaining rigorous regulatory oversight to protect patient safety and program sustainability.

yesterday
MJBizDaily